Financing During Times of Crisis by Strategic Partners/Investors

Howard Sterling, who focuses on cross-border international licensing especially in Health Tech, High Tech and Clean Tech, shows the win-win-win of small innovative companies raising funds by going to complementary, larger industrial partners, many times from another country, since the leading company needs innovative products and has cash.Education and Honors:
B.S. at Columbia University in Economics, 1962, with Honors, Cum Laude, Phi Beta Kappa;

LLB from Harvard Law School, 1965, Magna Cum Laude,
Harvard Law Review Editor: Law Review Note on Broker Dealer Bankruptcies.
Senior Honors Seminar Thesis on Broker Dealers Going Public; Published in the UCLA Law Journal.

Legal and professional background includes the following:

Law Firm: Founder and Senior Partner, Rifkind & Sterling, Beverly Hills, California: 1965 1983, premier West Coast Boutique law firm specializing in Securities Law, IPOs especially for technology and biotechnology companies; Did over 100 IPOs.

Investment Banking, 1983-2008,
•Rooney Pace, started and headed Investment Banking 1983-1987
•HJ Meyers, investment banking, 1988-1991; also reorganized and sold my deceased father-in-laws time share business, Preferred Equities.
•Oscar Gruss & Son, started and headed Investment Banking, 1991 1994 In Israel focused on Israeli Technology and Healthcare, did 11 Israeli IPOs and was co-CEO of Nitzanim Venture Fund, one of the first USA-style venture funds in Israel.
•Sands Brothers/Laidlaw, 1995 2005 COO of Venture Capital and Managing Director Technology and Healthcare, COO of $175 million High-technology Venture Fund;
•Laurus Fund (Managing Director Israel) 2005-2006;
•Carter Securities (Managing Director Healthcare and Technology) 2006-2007;
•National Securities (Managing Director healthcare and Technology) 2007-2008.
•Currently: Sterling Group, Managing Director: Healthcare and Cleantech Focus: China and Israel




Financings and Capabilities:
•As a securities attorney, investment banker or venture capitalist, have done over 150 IPOs for companies all over the world, UK, Belgium, Singapore, Taiwan, China and over 21 Israel IPOs on NASDAQ.
•Have done over 50 private placements and venture capital transactions as attorney, investment banker and venture capitalist.
•Can interact at PhD and MD level in fields such as immunology, genetic engineering, healthcare, high-technology (including photonics) and cleantech (including solar, wind, pollution cleanup, energy saving, advanced batteries and waste-to-energy).
•Know and have partnered with the major Funds all over the world in cleantech, healthcare and high-technology.
•Director and Chair of Audit Committee CAXG, largest publicly-held narcotics pharmaceutical company in China.

Category:

Science & Technology

Tags:

• STERLINGGROUPIntl
• Strategic
• Partnership
• Israel
• China
• Innovations
• Financing
• in
• Crisis
• Times
• Financial
• Help